N-[3-Fluoro-4-[(methylamino)carbonyl]phenyl]-2-methylalanine CAS:1289942-66-0
N-[3-Fluoro-4-[(methylamino)carbonyl]phenyl]-2-methylalanine finds applications in pharmaceutical research due to its unique structural attributes and potential pharmacological benefits. Here are its key uses: Drug Development: The compound is crucial in the development of pharmaceuticals targeting specific disease mechanisms. Its structure allows for modification to enhance therapeutic efficacy and reduce adverse effects. Cancer Research: Investigated for its potential as an anticancer agent, targeting tumor cells with specific receptor profiles. Research focuses on its role in inhibiting cancer cell proliferation or inducing apoptosis. Protein Structure Studies: Used as a tool in studying protein structure and function, particularly in understanding interactions with receptors or enzymes involved in disease pathways. Antibacterial Properties: Studies explore its antibacterial activity against resistant strains, contributing to the development of new antibiotics urgently needed in medical practice. Metabolic Disorders: Research examines its effects on metabolic pathways, potentially offering treatments for conditions such as diabetes or obesity by modulating metabolic functions. Neurological Disorders: Investigated for its neuroprotective effects and potential in treating neurological conditions characterized by neurodegeneration or neurotransmitter imbalances. Enzyme Inhibition: Its chemical structure makes it suitable for studying enzyme inhibition mechanisms, aiding in the design of enzyme-targeted therapies for metabolic and infectious diseases. Clinical Trials: Ongoing clinical trials assess the safety and efficacy of N-[3-Fluoro-4-[(methylamino)carbonyl]phenyl]-2-methylalanine in various patient populations, paving the way for potential therapeutic applications in medical practice. In summary, N-[3-Fluoro-4-[(methylamino)carbonyl]phenyl]-2-methylalanine is a versatile compound with significant potential in pharmaceutical research. Its structural characteristics and pharmacological activities make it valuable for developing new therapies targeting cancer, metabolic disorders, and other medically relevant pathways.
Composition | C12H15FN2O3 |
Assay | 99% |
Appearance | white powder |
CAS No. | 1289942-66-0 |
Packing | Small and bulk |
Shelf Life | 2 years |
Storage | Store in cool and dry area |
Certification | ISO. |